Abstract Details

Title Effects of Once-Daily Lamotrigine Extended-Release as Adjunctive Therapy in Patients with Primary Generalized Tonic-Clonic Seizures

Topic Epilepsy

Presentation(s) (-)

Poster/Presentation
Number 102

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Victor Biton, MD (AEP)	Dr. Biton has nothing to disclose.
Alain Vuong (GlaxoSmithKline)	No disclosure on file
Anne E. Hammer (Glaxo Welcome)	No disclosure on file
	No disclosure on file
Susan Kerls (GlaxoSmithKline)	No disclosure on file
John A. Messenheimer, Jr., MD	Dr. Messenheimer has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Zynerba Pharmaceuticals. Dr. Messenheimer has received intellectual property interests from a discovery or technology relating to health care. Dr. Messenheimer has received intellectual property interests from a discovery or technology relating to health care. Dr. Messenheimer has received intellectual property interests from a discovery or technology relating to health care.
	No disclosure on file

��ɫ��